
Mission
At Oncocross, we strive to develop drugs that can satisfy unmet medical needs through our AI platform. ONCO AI allows rare disease patients to receive the best treatment and partners to accelerate research and drug development. ONCOfind AI detects primary site of cancer with high accuracy. Accelerate drug development with Oncocross in less time with low cost.Milestone
Cancer Research UK
Material Transfer
AgreementSeries B Funding
KRW
16,500,000,000Columbia University
Medical CenterResearch Collaboration
Boehringer
IngelheimResearch Collaboration
Korea Pharma
License Out
Merck Accelerator
ProgramFinal Round Bootcamp
Ministry of SMEs
and StartupsBIG3
Jeil Pharmaceutical
License In
Ministry of Health
and Welfare표창장
Series A Funding
KRW
6,000,000,000

Contact Us
-
TEL
+82-2-867-9967
-
E-MAIL
oncocross
@oncocross.com -
FAX
+82-2-867-9968
-
ADDRESS
16F Gongdeok Bldg, Saechang-ro 11,
Mapo-gu, Seoul, Korea